|
Volumn 5, Issue 2, 2009, Pages 149-151
|
Infection and cancer: Biology, therapeutics and prevention
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZACITIDINE;
HEPATITIS B VACCINE;
HISTONE DEACETYLASE INHIBITOR;
WART VIRUS VACCINE;
CANCER VACCINE;
ANGIOGRAPHY;
BONE MARROW TRANSPLANTATION;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER PREVENTION;
CANCER STAGING;
CELL THERAPY;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONDYLOMA ACUMINATUM;
CONFERENCE PAPER;
CYTOTOXIC T LYMPHOCYTE;
DIAGNOSTIC TEST;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG TARGETING;
EARLY DIAGNOSIS;
ECHOGRAPHY;
HEPATITIS B;
HIGH RISK PATIENT;
HODGKIN DISEASE;
HUMAN;
INFECTION PREVENTION;
LABORATORY TEST;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LYMPHOPROLIFERATIVE DISEASE;
MALIGNANT NEOPLASTIC DISEASE;
NASOPHARYNX CARCINOMA;
NONHUMAN;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RECURRENT CANCER;
SEROLOGY;
STOMACH CANCER;
UTERINE CERVIX CANCER;
VIRUS INFECTION;
HELICOBACTER INFECTION;
MICROBIOLOGY;
NEOPLASM;
CANCER VACCINES;
CLINICAL TRIALS AS TOPIC;
HELICOBACTER INFECTIONS;
HUMANS;
NEOPLASMS;
TUMOR VIRUS INFECTIONS;
|
EID: 66349126880
PISSN: 14796694
EISSN: 17448301
Source Type: Journal
DOI: 10.2217/14796694.5.2.149 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|